Malaria

The WHO Global Malaria Programme at the 7th MIM Pan African Malaria Conference

15-20 April 2018
Dakar, Senegal

Speech by the Director of the Global Malaria Programme

Dr Pedro L. Alonso, Director of the Global Malaria Programme, will give a keynote speech on "Malaria control and management".

When: 16 April 2018 (08:30–09:30)
Where: Auditorium

Symposia

Symposium 25 – Malaria surveillance and elimination: country-driven and country owned

The objective of this symposium will to be to discuss the implementation and operationalization of new WHO guidance on malaria elimination and surveillance by national malaria elimination programmes. Participants will hear about the opportunities and challenges presented by malaria elimination and how to tailor malaria elimination intervention strategies to the continuum of transmission within a country.

Session chair
  • Ebenezer Baba, Medical Officer, WHO Regional Office for Africa
Speakers
  • Kim Lindblade, Elimination Team Lead, WHO Global Malaria Programme
  • Abdisalan Noor, Surveillance, Monitoring and Evaluation Team Lead, WHO Global Malaria Programme
  • Elizabeth Chizema, Director of the National Malaria Elimination Programme at the Ministry of Health, Zambia
  • Medoune Diop, Director of the National Malaria Control Programme, Senegal

When:17 April 2018 (14:30–16:15)
Where: PC Room

Symposium 31 – Overcoming barriers to access to malaria care through integrated community case management and engagement of the private sector

This symposium will present the results of the WHO-led Rapid Access Expansion (RAcE) 2015 Programme focused on reducing child mortality due to malaria, pneumonia and diarrhoea by increasing access to diagnostics, treatment and referral services for these diseases at the community level. It will also highlight current challenges and opportunities to ensure universal right for access to health care in remote rural areas most affected by malaria. Participants will also be informed on challenges and opportunities to increase access to quality malaria diagnostics and medicine in the informal private sector, to maximize impact on malaria mortality in high-burden countries of Africa.

Session chair
  • Rose Leke, Emeritus Professor of Immunology and Parasitology, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Cameroon
  • Fred Binka, Professor of Clinical Epidemiology, School of Public Health, University of Health and Allied Sciences, Ho, Ghana
Speakers
  • Andrea Bosman, Coordinator, Diagnostics, Treatment and Vaccines unit, WHO Global Malaria Programme
  • Salim Saddrudim, Team Lead, Rapid Access Expansion (RAcE) for integrated community case management of malaria, pneumonia and diarrhea, WHO Global Malaria Programme
  • George Jagoe, Executive Vice President for Access & Product Management at the Medicines for Malaria Venture
  • Theodoor Visser, senior manager of the Global Malaria Program for the Clinton Health Access Initiative (CHAI)

When: 17 April 2018 (16:45–18:30)
Where: Tente A

Symposium 56 – Introduction to the Malaria Vaccine Implementation Programme: The Pilot Implementation and Evaluation of the RTS,S/AS01 Malaria Vaccine in Children in Ghana, Kenya, and Malawi

The RTS,S/AS01 Malaria Vaccine has been shown to significantly reduce malaria morbidity, including severe malaria, when provided to children from 5 months of age in a 4-dose schedule. WHO has recommended pilot implementation of the vaccine to measure the feasibility of delivering the 4-dose vaccine regimen, safety of the vaccine in the context of routine use, and vaccine impact. We will describe the major components of the Malaria Vaccine Implementation Programme (MVIP), present the methodologies planned to evaluate the pilot implementation of the RTS,S/AS01 vaccine, and describe the timeline for the MVIP and policy decision.

Session chairs
  • Mary Hamel, Senior Technical Officer, and Lead Malaria Vaccine Implementation Programme, WHO Initiative for Vaccine Research
  • Fred Binka, Professor of Clinical Epidemiology, School of Public Health, University of Health and Allied Sciences, Ho, Ghana
Speakers
  • Rose Jalang'o, National Vaccines and Immunization Programme, Ministry of Health, Kenya
  • Patricia Njuguna, Medical Officer, Global Malaria Programme
  • Scott Gordon, Director Malaria Vaccine Implementation Programme for PATH
  • Nicolas Praet, Senior Epidemiologist, GSK Vaccines

When:19 April 2018 (16:45–18:30)
Where: Auditorium

Symposium 58 – Leaving no-one behind: achieving universal access to malaria interventions

To present evidence on the link between malaria programme coverage gaps and mortality in children under 5 years of age in Africa and the populations most affected by coverage gaps. Participants will also be informed of the most important bottlenecks in the delivery of programmes, promising strategies to overcome them and WHO’s call for action to alleviate coverage gaps.

Co-chairs
  • Elizabeth Chizema, Director of the National Malaria Elimination Programme at the Ministry of Health, Zambia
  • Awa Marie Coll Seck, Ministre d’Etat, Présidence de la République, Senegal
Speakers
  • Richard Cibulskis, Coordinator, Strategy, Evidence and Economics unit, WHO Global Malaria Programme
  • Jackson Sillah, acting Malaria Team Leader, WHO Regional Office for Africa
  • Andrea Bosman, Coordinator, Diagnostics, Treatment and Vaccines unit, WHO Global Malaria Programme
  • Pedro Alonso, Director of the WHO Global Malaria Programme

When:19 April 2018 (16:45–18:30)
Where: Tente A